These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21565595)

  • 1. Psychological factors affecting response to antidepressant drugs in fibromyalgia.
    Díaz-Marsá M; Palomares N; Morón MD; Tajima K; Fuentes ME; López-Ibor JJ; Carrasco JL
    Psychosomatics; 2011; 52(3):237-44. PubMed ID: 21565595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression.
    Hunter AM; Cook IA; Leuchter AF
    J Clin Psychopharmacol; 2010 Dec; 30(6):748-51. PubMed ID: 21057245
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant efficacy of venlafaxine.
    Golden RN; Nicholas L
    Depress Anxiety; 2000; 12 Suppl 1():45-9. PubMed ID: 11098413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open clinical trial of venlafaxine treatment of fibromyalgia.
    Dwight MM; Arnold LM; O'Brien H; Metzger R; Morris-Park E; Keck PE
    Psychosomatics; 1998; 39(1):14-7. PubMed ID: 9538670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose venlafaxine treatment in panic disorder.
    Papp LA; Sinha SS; Martinez JM; Coplan JD; Amchin J; Gorman JM
    Psychopharmacol Bull; 1998; 34(2):207-9. PubMed ID: 9641002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
    Sheehan DV
    J Clin Psychiatry; 2001; 62 Suppl 19():26-31. PubMed ID: 11577788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effects of venlafaxine extended release for patients with depressive and anxiety disorders in the German outpatient setting - results of 2 observational studies including 8500 patients].
    Anghelescu IG; Dierkes W; Volz HP; Loeschmann PA; Schmitt AB
    Fortschr Neurol Psychiatr; 2009 Nov; 77(11):646-54. PubMed ID: 19890774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.
    Chi MH; Chang HH; Lee SY; Lee IH; Gean PW; Yang YK; Lu RB; Chen PS
    J Affect Disord; 2010 Nov; 126(3):430-5. PubMed ID: 20674983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
    Davidson J; Baldwin DS; Stein DJ; Pedersen R; Ahmed S; Musgnung J; Benattia I; Rothbaum BO
    Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression.
    Hsiao CC
    Psychoneuroendocrinology; 2006 Aug; 31(7):839-46. PubMed ID: 16716529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine XR in the treatment of anxiety.
    Hackett D
    Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using psychostimulants for treating residual symptoms in major depression.
    Berlim MT; Turecki MG
    J Psychiatry Neurosci; 2007 Jul; 32(4):304. PubMed ID: 17653297
    [No Abstract]   [Full Text] [Related]  

  • 16. HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder.
    Bech P; Boyer P; Germain JM; Padmanabhan K; Haudiquet V; Pitrosky B; Tourian KA
    Pharmacopsychiatry; 2010 Nov; 43(7):271-6. PubMed ID: 20830664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine: loss of antidepressant effect and its management.
    Sharma V
    J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effectiveness of venlafaxine in peri- and postmenopausal patients with major depressive disorder.
    Iglesias García C; Ocio León S; Ortigosa Digón JC; Merino García MJ; Alonso Villa MJ; Fernández Palicio L; Alonso Rionda JL; García Fernández F; Rodríguez Colubi L; Toimil Iglesias A
    Actas Esp Psiquiatr; 2010; 38(6):326-31. PubMed ID: 21188671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial.
    Boyer P; Montgomery S; Lepola U; Germain JM; Brisard C; Ganguly R; Padmanabhan SK; Tourian KA
    Int Clin Psychopharmacol; 2008 Sep; 23(5):243-53. PubMed ID: 18703933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of venlafaxine extended release in elderly depressed patients.
    Ibor JJ; Carrasco JL; Prieto R; García-Calvo C;
    Arch Gerontol Geriatr; 2008; 46(3):317-26. PubMed ID: 17617478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.